Top Markets
Coin of the day
Becton, Dickinson and Company Becton, Dickinson and Company

Becton, Dickinson and Company

BDX
株式のランク #389
Becton, Dickinson and Company develops, manufactures, and sells medical... Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
株価
$154.51
時価総額
$55.98B
変化(1日)
-1.82%
変化(1年)
-32.08%
US
取引 Becton, Dickinson and Company (BDX)

カテゴリー

Becton, Dickinson and Company(BDX)の収益
Dec 2025 時点の収益 TTM: $21.92B
Becton, Dickinson and Company の最新の財務報告によると、現在の収益 (TTM) は $21.92B です。2024 年には $20.18B の収益があり、これは 2023 年の $19.37B と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Becton, Dickinson and Company の収益履歴(2000 ~ 2026)
各年末の収益
収益 変化
2026 (TTM) $21.92B 0.38%
2025 $21.84B 8.23%
2024 $20.18B 4.16%
2023 $19.37B 2.66%
2022 $18.87B -1.36%
2021 $19.13B 19.02%
2020 $16.07B -7.03%
2019 $17.29B 8.18%
2018 $15.98B 32.17%
2017 $12.09B -3.12%
2016 $12.48B 21.41%
2015 $10.28B 21.74%
2014 $8.45B 4.87%
2013 $8.05B 4.49%
2012 $7.71B 1.64%
2011 $7.58B 6.45%
2010 $7.12B 1.97%
2009 $6.99B -1.25%
2008 $7.07B 11.25%
2007 $6.36B 10.83%
2006 $5.74B 5.97%
2005 $5.41B 9.73%
2004 $4.93B 10.56%
2003 $4.46B 12.70%
2002 $3.96B 5.49%
2001 $3.75B 3.76%
2000 $3.62B 0.00%
同業他社の収益
企業 収益 収益の差
$10.06B -54.09%
US
$4.14B -81.12%
DE
$5.91B -73.04%
JP
$10.40B -52.56%
CH
$5.40B -75.38%
US